Barclays slashes price target on Thermo Fisher Scientific Inc [TMO] – find out why.

Misty Lee

Thermo Fisher Scientific Inc [NYSE: TMO] price surged by 9.42 percent to reach at $45.71.

A sum of 6084766 shares traded at recent session while its average daily volume was at 2.44M shares. Thermo Fisher Scientific Inc shares reached a high of $534.84 and dropped to a low of $486.94 until finishing in the latest session at $530.73.

The one-year TMO stock forecast points to a potential upside of 2.48. The average equity rating for TMO stock is currently 1.63, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Thermo Fisher Scientific Inc [TMO]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TMO shares is $544.23 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TMO stock is a recommendation set at 1.63. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Barclays have made an estimate for Thermo Fisher Scientific Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on September 11, 2025. While these analysts kept the previous recommendation, William Blair raised their target price to Outperform. The new note on the price target was released on August 19, 2025, representing the official price target for Thermo Fisher Scientific Inc stock. Previously, the target price had yet another raise to $510, while HSBC Securities analysts kept a Hold rating on TMO stock.

The Price to Book ratio for the last quarter was 3.97, with the Price to Cash per share for the same quarter was set at 16.93. Price to Free Cash Flow for TMO in the course of the last twelve months was 32.48 with Quick ratio for the last quarter at 1.50.

TMO Stock Performance Analysis:

Thermo Fisher Scientific Inc [TMO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.40. With this latest performance, TMO shares gained by 8.86% in over the last four-week period, additionally plugging by 9.89% over the last 6 months – not to mention a rise of 2.02% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TMO stock in for the last two-week period is set at 70.29, with the RSI for the last a single of trading hit 16.54, and the three-weeks RSI is set at 13.95 for Thermo Fisher Scientific Inc [TMO]. The present Moving Average for the last 50 days of trading for this stock 479.59, while it was recorded at 480.25 for the last single week of trading, and 477.77 for the last 200 days.

Insight into Thermo Fisher Scientific Inc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Thermo Fisher Scientific Inc [TMO] shares currently have an operating margin of 18.45% and a Gross Margin at 40.44%. Thermo Fisher Scientific Inc’s Net Margin is presently recorded at 15.24%.

Thermo Fisher Scientific Inc (TMO) Capital Structure & Debt Analysis

According to recent financial data for Thermo Fisher Scientific Inc. ( TMO), the Return on Equity (ROE) stands at 13.44%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 6.59%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Thermo Fisher Scientific Inc’s Return on Invested Capital (ROIC) is 7.88%, showcasing its effectiveness in deploying capital for earnings.

Thermo Fisher Scientific Inc (TMO) Efficiency & Liquidity Metrics

Based on Thermo Fisher Scientific Inc’s (TMO) latest financial statements, the Debt-to-Equity Ratio is 0.70%, indicating its reliance on debt financing relative to shareholder equity.

Thermo Fisher Scientific Inc (TMO) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Thermo Fisher Scientific Inc. (TMO) effectively leverages its workforce, generating an average of $52640.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.93% and a Quick Ratio of 1.50%, indicating strong ability to cover short-term liabilities.

TMO Stock EPS

With the latest financial reports released by the company, Thermo Fisher Scientific Inc posted 5.28/share EPS, while the average EPS was predicted by analysts to be reported at 5.25/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.03. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TMO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Thermo Fisher Scientific Inc go to 7.14%.

Thermo Fisher Scientific Inc [TMO] Institutonal Ownership Details

There are presently around $91.56%, or 91.71%% of TMO stock, in the hands of institutional investors. The top three institutional holders of TMO stocks are: VANGUARD GROUP INC with ownership of 32.73 million shares, which is approximately 8.5678%. BLACKROCK INC., holding 29.53 million shares of the stock with an approximate value of $$16.33 billion in TMO stocks shares; and BLACKROCK INC., currently with $$8.96 billion in TMO stock with ownership which is approximately 4.2393%.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.